Codexis (CDXS) Asset Writedowns and Impairment (2013 - 2025)
Codexis' quarterly Asset Writedowns and Impairment came in at -$113000.0 in Q1 2025, down 168.48% quarter-over-quarter from $165000.0 in Q2 2024.
Codexis has reported Asset Writedowns and Impairment for 6 years, with the latest figure at -$113000.0 in Q1 2025.
- For the quarter ending Q1 2025, Asset Writedowns and Impairment changed N/A year-over-year to -$113000.0; the trailing twelve-month figure through Dec 2025 stood at -$113000.0 (down 168.48% YoY), and the FY2024 full-year result was $165000.0, up 353.85% from the prior year.
- Asset Writedowns and Impairment for Q1 2025 stood at -$113000.0, down from $165000.0 in the prior quarter.
- The five-year high for Asset Writedowns and Impairment was $7.7 million in Q3 2023, with the low at -$10.0 million in Q4 2023.
- Average Asset Writedowns and Impairment over 4 years is -$391000.0, with a median of $165000.0 recorded in 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Codexis | 251.43 Mn | 186.29 Mn | 13.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -113,000.00 |
| Mar 31, 2025 | -113,000.00 |
| Jun 30, 2024 | 165,000.00 |
| Jun 30, 2024 | 165,000.00 |
| Dec 31, 2023 | -10.05 Mn |
| Dec 31, 2023 | -10.05 Mn |
| Sep 30, 2023 | 7.70 Mn |
| Sep 30, 2023 | 7.70 Mn |
| Dec 31, 2021 | 342,000.00 |
| Dec 31, 2021 | 342,000.00 |
| Dec 31, 2014 | 1.79 Mn |
| Dec 31, 2014 | 1.79 Mn |
| Sep 30, 2014 | 1.84 Mn |
| Sep 30, 2014 | 1.84 Mn |
| Jun 30, 2014 | 1.80 Mn |
| Jun 30, 2014 | 1.80 Mn |
| Dec 31, 2013 | 1.57 Mn |
| Dec 31, 2013 | 1.57 Mn |